Google Scholar citation report
Citations : 14978

Journal of Basic and Clinical Pharmacy received 14978 citations as per google scholar report

Indexed In

Xinh Don*
Department of Pharmacy, University of Sydney, Sydney, Australia
*Correspondence: Xinh Don, Department of Pharmacy, University of Sydney, Sydney, Australia, Email:

Received: 14-Nov-2023, Manuscript No. Jbclinphar-23-123541; Editor assigned: 16-Nov-2023, Pre QC No. Jbclinphar-23-123541 (PQ); Reviewed: 30-Nov-2023 QC No. Jbclinphar-23-123541; Revised: 07-Dec-2023, Manuscript No. Jbclinphar-23-123541 (R); Published: 14-Dec-2023

Citation: Don X. Development of Pharmacotherapy at Duration and with Technology. J Basic Clin Pharma.2023,14(6):317.

This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (, which permits reuse, distribution and reproduction of the article, provided that the original work is properly cited and the reuse is restricted to noncommercial purposes. For commercial reuse, contact


The field of medicine has demonstrated an important development in the available options for treatment in recent years. Pharmacotherapy, a field that has developed with advances in medical research and significantly influenced how we approach and manage a range of health issues, is one of the basis of this revolution.

Pharmacotherapy has its origins in the use of natural medicines by physicians to promote healing and relieve symptoms in ancient cultures. Early knowledge of plants therapeutic qualities is demonstrated by allusions to a variety of plant-based treatments found in the Ebers Papyrus, an ancient Egyptian medical document that dates back to 1550 BCE. Similar to this, the use of herbs and other natural substances for medicinal reasons has a long history in both traditional Chinese medicine and the Indian Ayurvedic system.

Pharmacotherapy go through a major change during the era of when the scientific approach became more widely accepted. In order to provide more specialized and efficient therapies, alchemists and early pharmacists experimented with separating active chemicals from plants and minerals. Important discoveries throughout the 19th century included the separation of morphine from drugs and the creation of aspirin, which completely changed the treatment of pain.

Modern pharmacotherapy

Modern pharmacotherapy developed in the 20th century, characterized by innovative discoveries and the creation of a wide range of pharmacological drugs. The discovery of antibiotics, which started with penicillin in 1928, transformed the way infectious illnesses were treated and helped save countless lives. The discovery of insulin in the 1920s changed the prognosis for those who had diabetes, converting a once- fatal illness into one that could be controlled.

The development of psychotropic drugs in the middle of the 20th century marked the start of a new era in the management of mental health issues. The first antipsychotic drug, chlorpromazine, was discovered in the 1950s, and this led to the deinstitutionalization of mental patients and the transition to community-based care.

Targeted treatments were made possible in the 20th century by developments in pharmacology and molecular biology. Chemotherapy changed the course of cancer treatment and gave people with terminal illnesses another chance of life. Monoclonal antibodies are one type of immunotherapy that has become a potent weapon in the battle against a wide range of illnesses, including autoimmune disorders and cancer.

Contemporary challenges in pharmacotherapy

The development of antibiotic resistance is one of the main issues, since it provides a chance that to world health and affects our capacity to successfully treat bacterial illnesses. Antibiotic abuse and misuse have led to the emergence of resistant strains, thus there has to be a concentrated effort to create novel antimicrobial medicines and encourage appropriate monitoring of antibiotics.

Another modern issue that highlights the unstable equilibrium between danger of drug dependence and pain treatment is the substance difficulties. The prescription of opioids for chronic pain has become commonplace and caused pain management methods to be analyzed and alternative therapies to be advanced.

The high cost of pharmaceuticals is a persistent issue that limits access to essential medications for many individuals, both in developed and developing countries. Efforts to provide affordable access to life-saving therapies and change problems in medication price are continuing, as is the complex relationship between pharmaceutical corporations, insurance providers, and regulators.

Opportunities and problems are caused by the study of pharmacogenomics, which is the way an individual’s genetic composition affects how they react to drugs. Even though customized medicine has the potential to customize care based on each patient’s distinct genetic profile, putting these strategies into practice on a broad scale would involve overcoming ethical, legal, and logistical challenges.